PLK2 and neoplasm: While recognizing that including AJ2 alone and sNK alone in this research would strengthen the conclusions, this study represents our initial bone analysis in tumor-bearing hu-BLT mice to assess the efficacy of AJ2 and/or sNK cell therapy in addressing tumor-induced bone defects.